Clarke P - Search Results

1

Modulation of Biliary Cancer Chemo-Resistance Through MicroRNA-Mediated Rewiring of the Expansion of CD133+ Cells.

Carotenuto P, Hedayat S, Fassan M, Cardinale V, Lampis A, Guzzardo V, Vicentini C, Scarpa A, Cascione L, Costantini D, Carpino G, Alvaro D, Ghidini M, Trevisani F, Te Poele R, Salati M, Ventura S, Vlachogiannis G, Hahne JC, Boulter L, Forbes SJ, Guest RV, Cillo U, Said-Huntingford I, Begum R, Smyth E, Michalarea V, Cunningham D, Rimassa L, Santoro A, Roncalli M, Kirkin V, Clarke P, Workman P, Valeri N, Braconi C. Carotenuto P, et al. Among authors: clarke p. Hepatology. 2020 Sep;72(3):982-996. doi: 10.1002/hep.31094. Epub 2020 Sep 10. Hepatology. 2020. PMID: 31879968 Free PMC article.

2

Bcl-2 expression and response to chemotherapy in colorectal adenocarcinomas.

Schneider HJ, Sampson SA, Cunningham D, Norman AR, Andreyev HJ, Tilsed JV, Clarke PA. Schneider HJ, et al. Among authors: clarke pa. Br J Cancer. 1997;75(3):427-31. doi: 10.1038/bjc.1997.70. Br J Cancer. 1997. PMID: 9020491 Free PMC article.

3

K-ras mutations in patients with early colorectal cancers.

Andreyev HJ, Tilsed JV, Cunningham D, Sampson SA, Norman AR, Schneider HJ, Clarke PA. Andreyev HJ, et al. Among authors: clarke pa. Gut. 1997 Sep;41(3):323-9. doi: 10.1136/gut.41.3.323. Gut. 1997. PMID: 9378386 Free PMC article.

4

Kirsten ras mutations in patients with colorectal cancer: the multicenter "RASCAL" study.

Andreyev HJ, Norman AR, Cunningham D, Oates JR, Clarke PA. Andreyev HJ, et al. Among authors: clarke pa. J Natl Cancer Inst. 1998 May 6;90(9):675-84. doi: 10.1093/jnci/90.9.675. J Natl Cancer Inst. 1998. PMID: 9586664

5

Phase I clinical and pharmacokinetic study of bcl-2 antisense oligonucleotide therapy in patients with non-Hodgkin's lymphoma.

Waters JS, Webb A, Cunningham D, Clarke PA, Raynaud F, di Stefano F, Cotter FE. Waters JS, et al. Among authors: clarke pa. J Clin Oncol. 2000 May;18(9):1812-23. doi: 10.1200/JCO.2000.18.9.1812. J Clin Oncol. 2000. PMID: 10784621 Clinical Trial.

6

Gene expression profiling of human colon cancer cells following inhibition of signal transduction by 17-allylamino-17-demethoxygeldanamycin, an inhibitor of the hsp90 molecular chaperone.

Clarke PA, Hostein I, Banerji U, Stefano FD, Maloney A, Walton M, Judson I, Workman P. Clarke PA, et al. Oncogene. 2000 Aug 24;19(36):4125-33. doi: 10.1038/sj.onc.1203753. Oncogene. 2000. PMID: 10962573

7

Antisense treatment directed against mutated Ki-ras in human colorectal adenocarcinoma.

Andreyev HJ, Ross PJ, Cunningham D, Clarke PA. Andreyev HJ, et al. Among authors: clarke pa. Gut. 2001 Feb;48(2):230-7. doi: 10.1136/gut.48.2.230. Gut. 2001. PMID: 11156646 Free PMC article.

8

Inhibition of signal transduction by the Hsp90 inhibitor 17-allylamino-17-demethoxygeldanamycin results in cytostasis and apoptosis.

Hostein I, Robertson D, DiStefano F, Workman P, Clarke PA. Hostein I, et al. Among authors: clarke pa. Cancer Res. 2001 May 15;61(10):4003-9. Cancer Res. 2001. PMID: 11358818

9

Innovative cancer drug targets: genomics, transcriptomics and clinomics.

Workman P, Clarke PA. Workman P, et al. Among authors: clarke pa. Expert Opin Pharmacother. 2001 Jun;2(6):911-5. doi: 10.1517/14656566.2.6.911. Expert Opin Pharmacother. 2001. PMID: 11585007 No abstract available.

10

Preclinical antitumor activity and pharmacodynamic studies with the farnesyl protein transferase inhibitor R115777 in human breast cancer.

Kelland LR, Smith V, Valenti M, Patterson L, Clarke PA, Detre S, End D, Howes AJ, Dowsett M, Workman P, Johnston SR. Kelland LR, et al. Among authors: clarke pa. Clin Cancer Res. 2001 Nov;7(11):3544-50. Clin Cancer Res. 2001. PMID: 11705875

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,177 results

Search Page